Silica Corpora GmbH

"Silica Corpora is a Berlin-based biotech startup applying generative AI for the de novo design of antibody therapeutics. The AI platform ""MALI"" generates tailored antibody candidates (CDRs) from scratch and optimizes their binding affinity based on vast sequence-based training datasets—reducing the lead generation process from years to just a few days. The target audience includes pharmaceutical companies and biotech firms looking to develop novel antibody drug candidates for difficult-to-treat diseases faster and more cost-efficiently."